Joseph Raffetto
Cardiovascular Disease · Salisbury, MDNPI 1831175397
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) at 30.0% of the total. Reporting peaked in 2019 at $826 and has fallen 86.6% since, to $110 in 2023.
Across 123 payments — averaging $17.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$642
- AstraZeneca$306
- E.r. Squibb & Sons, L.L.C.$172
- Amgen$163
- Johnson & Johnson$148
- Boehringer Ingelheim$106
- plus $602 from 15 others
What the payments were for
- Food & beverage$2,11999%
- Education$211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 37 | $642 |
| AstraZeneca | 20 | $306 |
| E.r. Squibb & Sons, L.L.C. | 11 | $172 |
| Amgen | 8 | $163 |
| Johnson & Johnson | 9 | $148 |
| Boehringer Ingelheim | 5 | $106 |
| Novartis | 5 | $96 |
| Amarin Pharma, Inc. | 5 | $79 |
| Regeneron Healthcare Solutions, Inc. | 4 | $72 |
| Cardiovascular Systems Inc. | 2 | $50 |
| Medtronic(2 entities) | 2 | $46 |
| Abbott | 2 | $43 |
| Cardinal Health 200 LLC | 3 | $41 |
| Pfizer | 2 | $34 |
| Merck | 2 | $28 |
| Merz North America, Inc. | 1 | $27 |
| Atricure, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $19 |
| Cvrx, Inc. | 1 | $18 |
| Philips North America LLC | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
How this compares
$2,139 in reported general payments places this provider in the 55th percentile of 507 cardiovascular disease providers in Maryland.
Other cardiovascular disease in Salisbury
- Navin KapurBaltimore$1.5M
- Michael BlahaBaltimore$609K
- Sanjay RajagopalanBaltimore$521K
- Allen TaylorN Bethesda$456K
- David GoorayLargo$333K
- Erin MichosBaltimore$257K
- Seth MartinBaltimore$166K
- Erika FellerBaltimore$121K
- Mark HaigneyBethesda$121K
- Charles CummingsBaltimore$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.